Common Contracts
2 similar Collaborative Research and License Agreement contracts by Dicerna Pharmaceuticals Inc
EX-10.30 2 d507480dex1030.htm EX-10.30 CONFIDENTIAL ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under Contract number: [***] COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between...Collaborative Research and License Agreement • May 5th, 2020
WHEREAS BOEHRINGER is a research-based pharmaceutical company and is interested in a research program related to DICERNA’s proprietary GalXC technology which enables precise silencing of disease-driving genes in the liver, specifically targeting the hepatocyte.
Contract number: [***] COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between Boehringer Ingelheim International GmbH Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (“BOEHRINGER”) VAT-ID-No.: DE [***] and Dicerna Pharmaceuticals Inc. Cambridge,...Collaborative Research and License Agreement • March 8th, 2018 • Dicerna Pharmaceuticals Inc • Pharmaceutical preparations
WHEREAS BOEHRINGER is a research-based pharmaceutical company and is interested in a research program related to DICERNA’s proprietary GalXC technology which enables precise silencing of disease-driving genes in the liver, specifically targeting the hepatocyte.
